Table 5 |
|||||
|
Lipid Levels. |
|||||
|
Group |
Time 0 |
4 weeks |
8 weeks |
%Δ 0–4 wks |
%Δ 0–8 wks |
|
|
|||||
|
OP |
|||||
|
Cholesterol |
195.7 |
-13.30 ± 12.20 |
-14.80 ± 16.83 |
-7.2* |
-8.0* |
|
HDL |
69.8 |
0.86 ± 0.95 |
-0.87 ± 5.72 |
1.2 |
-1.3 |
|
LDL |
89.3 |
-12.64 ± 16.49 |
-13.01 ± 16.89 |
-13.8* |
-14.2* |
|
Triglycerides |
124.8 |
-7.85 ± 10.5 |
-4.58 ± 7.82 |
-6.3* |
-3.7* |
|
OT |
|||||
|
Cholesterol |
194.5 |
-31.6 ± 20.68 |
-43.45 ± 20.96 |
-15.8* |
-21.7* |
|
HDL |
69.7 |
3.37 ± 10.64 |
8.33 ± 13.25 |
4.8 |
11.8* |
|
LDL |
105.9 |
-32.99 ± 23.61 |
-47.47 ± 22.24 |
-31.0* |
-44.6* |
|
Triglycerides |
118.4 |
-16.52 ± 21.78 |
-21.57 ± 22.97 |
-13.9* |
-18.1* |
|
NP |
|||||
|
Cholesterol |
197.3 |
-9.83 ± 12.91 |
14.88 ± 13.37 |
-4.8 |
-7.3* |
|
HDL |
63.6 |
-0.36 ± 6.91 |
4.3 ± 4.88 |
-0.6 |
6.8 |
|
LDL |
123.6 |
-8.82 ± 17.36 |
-18.02 ± 14.38 |
-7.1 |
-14.5* |
|
Triglycerides |
86.0 |
-3.27 ± 2.38 |
-5.83 ± 8.30 |
-3.8* |
-6.8 |
|
NT |
|||||
|
Cholesterol |
197.0 |
-14.77 ± 15.51 |
-19.45 ± 16.26 |
-7.3* |
-9.7* |
|
HDL |
67.3 |
0.50 ± 4.58 |
2.63 ± 2.96 |
0.74 |
3.9* |
|
LDL |
116.0 |
-12.80 ± 15.86 |
-19.51 ± 16.89 |
-11.0* |
-16.8* |
|
Triglycerides |
88.7 |
-12.33 ± 6.50 |
-12.82 ± 6.03 |
-13.9* |
-14.5* |
|
|
|||||
|
*Significant P values < 0.05. OP = overweight placebo, OT = overweight treatment, NP = normal weight placebo and NT = normal weight treatment. Values at the start of the study (Time 0) listed in the first column are means of data from individuals. Mean changes after 4 weeks and 8 weeks are listed in the second and third columns as ± Standard Deviation. A negative value indicated a decrease in value and a positive number represents an increase in value. %Δ values are percent mean change in value between time 0 and either 4 or 8 weeks. Values* are significant P-value comparisons (< 0.05) between initial values at Time 0 and either 4 weeks or 8 weeks. |
|||||
|
Oben et al. Nutrition Journal 2008 7:16 doi:10.1186/1475-2891-7-16 |
|||||